According to the sequence of the bile salt hydrolase （BSH） gene of Bifidobacterium and the restriction enzyme cutting sites of expression vector pNZ8148, primers were designed and the bile salt hydrolase （BSH） gen...According to the sequence of the bile salt hydrolase （BSH） gene of Bifidobacterium and the restriction enzyme cutting sites of expression vector pNZ8148, primers were designed and the bile salt hydrolase （BSH） gene was gotten from Bacillus bifidus ATCC 29521 by PCR. BSH gene was inserted into lactic acid bacteria expression vector pNZ8148 to construct the recombinant pNZ8148-BSH. The recombinant pNZ8148-BSH was transferred into lactic acid bacteria NZ9000 with electrotransformation method. And the recombinant which could express BSH protein was obtained. It was identified by SDS-PAGE electrophoresis and activity verification. The result could provide a rationale reference for expressing BSH in lactic acid bacteria.展开更多
We cloned and expressed bile salt hydrolase gene ofLactobacillus plantarum M1-UVS29 in Lactococcus lactis NZ9000 successfully. Gene-specific primers for amplification of L. plantarum bsh were designed by using sequenc...We cloned and expressed bile salt hydrolase gene ofLactobacillus plantarum M1-UVS29 in Lactococcus lactis NZ9000 successfully. Gene-specific primers for amplification of L. plantarum bsh were designed by using sequence which availabled from GenBank. The production of PCR amplicon was confirmed by sequencing and cloned into pMD18-T vector, and then recombined into expression vector pNZ8148 and yielding vector pNZ8148-BSH, pNZ8148-BSH was transferred into Lactococcus lactis NZ9000. Sequencing indicated that the cloned bsh fragment contained 995 nucleotides, and shared 99.3% sequence homology with bsh gene from L. plantarum MBUL10. Cloned bsh fragment was successfully transduced into NICE expression system and confirmed by PCR and restriction digest. Recombinant BSH protein was analyzed by SDS-PAGE. The molecular weight of BSH protein was approximately 37 ku. Activity of the expressed protein was 0.77 μmol· min^-1. The successfully expressed proteins by genetic engineering technology made the function of lactic acid bacteria be abundant and laid the foundation for further researches into cholesterol-lowering lactic acid bacterium food and probiotics.展开更多
为筛选高产胆盐水解酶的乳杆菌,探究其对新生儿黄疸的防治作用。采用添加了25 U/mL制霉菌素的LBS选择性培养基,从健康新生儿粪便和母乳中筛选乳杆菌并鉴定种类;以鼠李糖乳杆菌LGG为阳性对照,体外评估菌株的益生菌特性;利用盐酸苯肼诱导...为筛选高产胆盐水解酶的乳杆菌,探究其对新生儿黄疸的防治作用。采用添加了25 U/mL制霉菌素的LBS选择性培养基,从健康新生儿粪便和母乳中筛选乳杆菌并鉴定种类;以鼠李糖乳杆菌LGG为阳性对照,体外评估菌株的益生菌特性;利用盐酸苯肼诱导新生SD大鼠黄疸模型,通过分析血清胆红素水平和肝脏组织的损伤情况,以及肝脏炎症因子、核转录因子的相对表达水平,探究高产胆盐水解酶乳杆菌对新生大鼠黄疸的防治作用及机制。结果表明,来自婴儿粪便的格氏乳杆菌FWJL-5在体外具良好的益生特性,并且产胆盐水解酶能力优于LGG,能够显著缓解新生大鼠胆红素水平升高、肝脏组织肿胀和溶血症状,减少肝脏损伤中肝酶的释放,抑制促炎因子的分泌,促进UGt1A1和上游核转录因子孕烷X受体(pregnane X receptor,pXR)、法尼醇X受体(farnesol X receptor,FXR)的表达。综上所述,婴儿粪便来源的格氏乳杆菌FWJL-5可通过上调核受体FXR/pXR促进UGt1A1表达以调节肝脏胆红素代谢,从而减轻新生大鼠黄疸症状,本研究可为格氏乳杆菌防治新生儿黄疸提供新思路。展开更多
对来源于Lactobacillus plantarum ST-Ⅲ菌株的胆盐水解酶基因bsh1在工程菌E.coli BL21/pET28b-bsh1中的表达条件进行了优化。首先通过一系列单因素实验对影响工程菌发酵条件的因素水平进行筛选。然后将诱导培养时间、诱导剂异丙基硫代-...对来源于Lactobacillus plantarum ST-Ⅲ菌株的胆盐水解酶基因bsh1在工程菌E.coli BL21/pET28b-bsh1中的表达条件进行了优化。首先通过一系列单因素实验对影响工程菌发酵条件的因素水平进行筛选。然后将诱导培养时间、诱导剂异丙基硫代-β-D-半乳糖苷(isopropylthio-D-galactoside,IPTG)浓度、胆盐浓度、装液量4个影响因素进行正交试验。在最佳工艺条件下得到的胆盐水解酶BSH比酶活达817.73 U。展开更多
This study investigated if the variation in the effect of anti-cholesterol(AC)treatment on individual mice are related to gut microbiome composition.The bile salt hydrolase(BSH)activity of 23 commercial fermented milk...This study investigated if the variation in the effect of anti-cholesterol(AC)treatment on individual mice are related to gut microbiome composition.The bile salt hydrolase(BSH)activity of 23 commercial fermented milk products was examined to select a fermented milk product for AC treatment.Mice were fed to different diets for 6 weeks:high-fat(60%of total calories from fat;D1),high-dietary fibre(20%cellulose;D2),and low-fat(17.2%of total calories from fat;D3)diets to change their gut microbiomes.Subsequently,faecal microbiome was transplanted(FMT)into mice treated with high cholesterol diet contained 2%cholesterol,followed by AC or non-AC(sterile tap water,STW)treatments.Control groups with normal(NC)and highcholesterol diets(PC)were prepared for both AC and STW treatment.All experimental groups were subjected to serum and liver cholesterol,cholesterol metabolism-related(CMR)gene expression,and intestinal microbiome analyses.D3-FMT mice showed the most significant enhancements in cholesterol ratio and decreased hepatic cholesterol levels with AC treatment.Moreover,upregulation of the Cyp7a1 gene expression was observed in this group.Furthermore,the intestinal microbiome analysis indicated higher abundances of BSH-producing Eubacterium,Bifidobacterium,and Parabacteroides in the D3-FMT+AC group compare to others,potentially contributing to increased bile acid synthesis.展开更多
胆盐水解酶(Bile salt hydrolase,BSH)广泛存在于哺乳动物胃肠道中,是肠道菌群在生长、繁殖过程中产生的一种胞内酶,可以调节宿主的胆汁酸平衡,影响脂质代谢,有控制胆固醇、调节肠道疾病的作用,并且BSH这种调控作用可以实现益生菌部分...胆盐水解酶(Bile salt hydrolase,BSH)广泛存在于哺乳动物胃肠道中,是肠道菌群在生长、繁殖过程中产生的一种胞内酶,可以调节宿主的胆汁酸平衡,影响脂质代谢,有控制胆固醇、调节肠道疾病的作用,并且BSH这种调控作用可以实现益生菌部分益生功能,因此BSH一直是研究热点。BSH结构和底物特异性的详细知识是开发BSH相关产品的坚实基础。本文介绍了BSH的来源及活性检测方法,BSH基因结构、酶学性质及底物识别机制,最后讨论了BSH在畜禽业食品工业及医药等方面的应用,期望为胆盐水解酶的深入研究及其在食品、保健品及医药方面的开发利用提供参考。展开更多
利用从藏灵菇中筛选的产胆盐水解酶的干酪乳杆菌Lactobacillus casei KL1研究影响胆盐水解酶酶活力的环境因素和超声波细胞破碎条件,探讨产酶能力的检测方法;采用四因素三水平[L9(34)]正交试验研究胆盐水解酶的优化发酵条件,利用完全交...利用从藏灵菇中筛选的产胆盐水解酶的干酪乳杆菌Lactobacillus casei KL1研究影响胆盐水解酶酶活力的环境因素和超声波细胞破碎条件,探讨产酶能力的检测方法;采用四因素三水平[L9(34)]正交试验研究胆盐水解酶的优化发酵条件,利用完全交叉组合试验研究超声波细胞破碎的最适条件,并应用牛津杯试验定性检测KL1菌株产胆盐水解酶的能力;优化发酵条件:葡萄糖添加量为2%、大豆蛋白胨添加量为2%、发酵温度为37℃、接种量为2%;细胞破碎最适条件:超声波功率为700W,3s间歇,5s工作,持续工作15min,控制温度范围0～6℃。在优化发酵条件下,胆盐水解酶的活力是优化前的7.4倍;在超声波细胞破碎最适条件下,细胞破碎率能达到80%的要求,并可检出胆盐水解酶活性;牛津杯试验结果表明Lactobacillus casei KL1菌株产生的胆盐水解酶具有降低胆固醇的功效。展开更多
基金Supported by 863 Projects (2008AA10Z311)National Science and Technology Support Projects (2009BADB9B06)+1 种基金Started Post-doctoral Research Grant of Heilongjiang Province (LBH-Q07023)Harbin Technological Innovation of Special Funds (2007RFQXN020)
文摘According to the sequence of the bile salt hydrolase （BSH） gene of Bifidobacterium and the restriction enzyme cutting sites of expression vector pNZ8148, primers were designed and the bile salt hydrolase （BSH） gene was gotten from Bacillus bifidus ATCC 29521 by PCR. BSH gene was inserted into lactic acid bacteria expression vector pNZ8148 to construct the recombinant pNZ8148-BSH. The recombinant pNZ8148-BSH was transferred into lactic acid bacteria NZ9000 with electrotransformation method. And the recombinant which could express BSH protein was obtained. It was identified by SDS-PAGE electrophoresis and activity verification. The result could provide a rationale reference for expressing BSH in lactic acid bacteria.
基金Supported by the National Natural Science Fund Project(31171657)Heilongjiang Province Natural Fund Project(ZD201207)Heilongjiang Province Postdoctoral Special Funds(LBH-Q13133)
文摘We cloned and expressed bile salt hydrolase gene ofLactobacillus plantarum M1-UVS29 in Lactococcus lactis NZ9000 successfully. Gene-specific primers for amplification of L. plantarum bsh were designed by using sequence which availabled from GenBank. The production of PCR amplicon was confirmed by sequencing and cloned into pMD18-T vector, and then recombined into expression vector pNZ8148 and yielding vector pNZ8148-BSH, pNZ8148-BSH was transferred into Lactococcus lactis NZ9000. Sequencing indicated that the cloned bsh fragment contained 995 nucleotides, and shared 99.3% sequence homology with bsh gene from L. plantarum MBUL10. Cloned bsh fragment was successfully transduced into NICE expression system and confirmed by PCR and restriction digest. Recombinant BSH protein was analyzed by SDS-PAGE. The molecular weight of BSH protein was approximately 37 ku. Activity of the expressed protein was 0.77 μmol· min^-1. The successfully expressed proteins by genetic engineering technology made the function of lactic acid bacteria be abundant and laid the foundation for further researches into cholesterol-lowering lactic acid bacterium food and probiotics.
文摘为筛选高产胆盐水解酶的乳杆菌,探究其对新生儿黄疸的防治作用。采用添加了25 U/mL制霉菌素的LBS选择性培养基,从健康新生儿粪便和母乳中筛选乳杆菌并鉴定种类;以鼠李糖乳杆菌LGG为阳性对照,体外评估菌株的益生菌特性;利用盐酸苯肼诱导新生SD大鼠黄疸模型,通过分析血清胆红素水平和肝脏组织的损伤情况,以及肝脏炎症因子、核转录因子的相对表达水平,探究高产胆盐水解酶乳杆菌对新生大鼠黄疸的防治作用及机制。结果表明,来自婴儿粪便的格氏乳杆菌FWJL-5在体外具良好的益生特性,并且产胆盐水解酶能力优于LGG,能够显著缓解新生大鼠胆红素水平升高、肝脏组织肿胀和溶血症状,减少肝脏损伤中肝酶的释放,抑制促炎因子的分泌,促进UGt1A1和上游核转录因子孕烷X受体(pregnane X receptor,pXR)、法尼醇X受体(farnesol X receptor,FXR)的表达。综上所述,婴儿粪便来源的格氏乳杆菌FWJL-5可通过上调核受体FXR/pXR促进UGt1A1表达以调节肝脏胆红素代谢,从而减轻新生大鼠黄疸症状,本研究可为格氏乳杆菌防治新生儿黄疸提供新思路。
文摘对来源于Lactobacillus plantarum ST-Ⅲ菌株的胆盐水解酶基因bsh1在工程菌E.coli BL21/pET28b-bsh1中的表达条件进行了优化。首先通过一系列单因素实验对影响工程菌发酵条件的因素水平进行筛选。然后将诱导培养时间、诱导剂异丙基硫代-β-D-半乳糖苷(isopropylthio-D-galactoside,IPTG)浓度、胆盐浓度、装液量4个影响因素进行正交试验。在最佳工艺条件下得到的胆盐水解酶BSH比酶活达817.73 U。
基金supported by the National Research Foundation of Korea(NRF)grant funded by the Korea government(MSIT)(2019R1A2C2004356).
文摘This study investigated if the variation in the effect of anti-cholesterol(AC)treatment on individual mice are related to gut microbiome composition.The bile salt hydrolase(BSH)activity of 23 commercial fermented milk products was examined to select a fermented milk product for AC treatment.Mice were fed to different diets for 6 weeks:high-fat(60%of total calories from fat;D1),high-dietary fibre(20%cellulose;D2),and low-fat(17.2%of total calories from fat;D3)diets to change their gut microbiomes.Subsequently,faecal microbiome was transplanted(FMT)into mice treated with high cholesterol diet contained 2%cholesterol,followed by AC or non-AC(sterile tap water,STW)treatments.Control groups with normal(NC)and highcholesterol diets(PC)were prepared for both AC and STW treatment.All experimental groups were subjected to serum and liver cholesterol,cholesterol metabolism-related(CMR)gene expression,and intestinal microbiome analyses.D3-FMT mice showed the most significant enhancements in cholesterol ratio and decreased hepatic cholesterol levels with AC treatment.Moreover,upregulation of the Cyp7a1 gene expression was observed in this group.Furthermore,the intestinal microbiome analysis indicated higher abundances of BSH-producing Eubacterium,Bifidobacterium,and Parabacteroides in the D3-FMT+AC group compare to others,potentially contributing to increased bile acid synthesis.
文摘胆盐水解酶(Bile salt hydrolase,BSH)广泛存在于哺乳动物胃肠道中,是肠道菌群在生长、繁殖过程中产生的一种胞内酶,可以调节宿主的胆汁酸平衡,影响脂质代谢,有控制胆固醇、调节肠道疾病的作用,并且BSH这种调控作用可以实现益生菌部分益生功能,因此BSH一直是研究热点。BSH结构和底物特异性的详细知识是开发BSH相关产品的坚实基础。本文介绍了BSH的来源及活性检测方法,BSH基因结构、酶学性质及底物识别机制,最后讨论了BSH在畜禽业食品工业及医药等方面的应用,期望为胆盐水解酶的深入研究及其在食品、保健品及医药方面的开发利用提供参考。
文摘利用从藏灵菇中筛选的产胆盐水解酶的干酪乳杆菌Lactobacillus casei KL1研究影响胆盐水解酶酶活力的环境因素和超声波细胞破碎条件,探讨产酶能力的检测方法;采用四因素三水平[L9(34)]正交试验研究胆盐水解酶的优化发酵条件,利用完全交叉组合试验研究超声波细胞破碎的最适条件,并应用牛津杯试验定性检测KL1菌株产胆盐水解酶的能力;优化发酵条件:葡萄糖添加量为2%、大豆蛋白胨添加量为2%、发酵温度为37℃、接种量为2%;细胞破碎最适条件:超声波功率为700W,3s间歇,5s工作,持续工作15min,控制温度范围0～6℃。在优化发酵条件下,胆盐水解酶的活力是优化前的7.4倍;在超声波细胞破碎最适条件下,细胞破碎率能达到80%的要求,并可检出胆盐水解酶活性;牛津杯试验结果表明Lactobacillus casei KL1菌株产生的胆盐水解酶具有降低胆固醇的功效。
